Coronaviruses are a large family of viruses that infect the respiratory tract, ranging from the common cold to severe pneumonia. Seven types are known to infect humans, and the most recent, SARS-CoV-2, caused the COVID-19 pandemic that began in late 2019. The name “coronavirus” comes from the Latin word for crown, describing the halo of spike proteins visible on the virus’s surface under a microscope.
The Coronavirus Family
Coronaviruses split into four groups: alpha, beta, gamma, and delta. Only the alpha and beta groups include viruses that infect people. Two alphacoronaviruses (known as 229E and NL63) and five betacoronaviruses make up the seven human-infecting types. Four of these seven cause mild colds and circulate every year without much attention. The other three have caused serious outbreaks.
SARS-CoV emerged in Guangdong, China in 2002, infecting about 8,098 people and killing 774, a fatality rate around 10%. About a decade later, MERS-CoV appeared in the Middle East, infecting 2,458 people with a much higher fatality rate of roughly 35%. SARS-CoV-2, which surfaced in Wuhan, China in December 2019, spread far more widely than either predecessor, with a lower fatality rate of approximately 4% in early estimates. Its combination of high transmissibility and a long infectious window before symptoms appear made it extraordinarily difficult to contain.
How the Virus Is Built
Coronaviruses are enveloped viruses, meaning each particle is wrapped in a fatty membrane stolen from the cells it previously infected. Inside that envelope sits a single strand of RNA, the genetic blueprint the virus uses to copy itself. Coronaviruses carry some of the largest RNA genomes of any virus.
Studding the outer membrane are spike proteins, large molecules that project outward in clusters of three. These spikes give the virus its crown-like appearance and serve a critical function: they latch onto a specific protein on human cells called ACE2, which is found on cells lining the airways, lungs, gut, and blood vessels. Once the spike protein locks onto ACE2, a human enzyme on the cell surface cuts the spike at a precise point, triggering the virus to fuse with the cell membrane and inject its RNA inside. From there, the cell’s own machinery starts producing copies of the virus.
How It Spreads
Coronaviruses spread primarily through respiratory droplets, the small particles released when an infected person coughs, sneezes, talks, or breathes. Close contact (generally within about six feet) carries the highest risk. In certain medical settings where aerosol-generating procedures are performed, such as intubation or nebulizer treatments, the virus can become suspended in finer particles that linger in the air longer.
Surface transmission received significant early attention, but detecting viral genetic material on a surface is not the same as finding live, infectious virus. The practical risk from touching contaminated surfaces turned out to be much lower than the risk from breathing in droplets directly. Fecal transmission has been explored as a possibility, since the virus can appear in stool, but no confirmed cases of fecal-oral spread have been documented.
Incubation and Symptoms
The time between exposure and first symptoms has shifted as the virus has evolved. Early strains of SARS-CoV-2 had a mean incubation period of about 6.5 days. The Delta variant shortened that to around 4.3 days, and Omicron variants brought it down further to a median of 3 to 4 days.
Common symptoms include fever, cough, fatigue, sore throat, congestion, and loss of taste or smell (though this last symptom became less common with later variants). Most people experience mild to moderate illness. Severe cases can progress to pneumonia and difficulty breathing, particularly in older adults or people with underlying health conditions like diabetes, heart disease, or weakened immune systems.
Testing and Diagnosis
PCR tests remain the gold standard for detecting a coronavirus infection. These tests look for specific fragments of the virus’s genetic material and are both highly sensitive and highly specific. The drawback is turnaround time, which can range from hours to a couple of days depending on lab capacity.
Rapid antigen tests offer results in about 15 minutes. They are very good at confirming a positive result (high specificity), but they are less sensitive than PCR tests, meaning they can miss infections, especially in the early days before viral load peaks. Sensitivity also varies by brand and by where someone is in the course of illness. A negative rapid test does not guarantee you’re uninfected, particularly if you have symptoms. Repeating the test 24 to 48 hours later improves accuracy.
Treatment Options
For people at higher risk of severe illness, antiviral medications can reduce the chance of hospitalization if started early. The preferred oral antiviral is a combination pill (marketed as Paxlovid) taken twice daily for five days, ideally started within five days of symptom onset. It’s approved for adults and authorized for children 12 and older who weigh at least 88 pounds. A second option is an intravenous antiviral (remdesivir) given as a 30- to 120-minute infusion on three consecutive days, started within seven days of symptoms. A third oral antiviral, molnupiravir, is available when the first two options aren’t suitable.
For most healthy people with mild symptoms, treatment is supportive: rest, fluids, and over-the-counter medications for fever and pain. Vaccination remains the most effective tool for preventing severe disease, hospitalization, and death, with updated formulations released periodically to match circulating variants.
Long COVID
A substantial number of people experience symptoms that persist well beyond the initial infection. A meta-analysis covering over 1.28 million survivors found that 49% reported at least one lingering symptom within 12 months of infection. The most common complaints include post-exertional malaise (worsening symptoms after physical or mental effort, reported by 87% of long COVID patients in one large tracking study), fatigue (85%), brain fog (64%), dizziness (62%), gastrointestinal problems (59%), and heart palpitations (57%).
Over longer periods, neurological and psychiatric symptoms tend to dominate. South Korean data tracking patients up to two years after infection found fatigue in about 35% of people, memory impairment in 30%, difficulty concentrating in 24%, insomnia in 21%, and depression in 20%. These numbers have generally declined with later variants and with vaccination, but long COVID remains a significant concern for a virus that has infected billions of people worldwide.
Where the Virus Stands Now
As of early 2026, no SARS-CoV-2 variants meet the criteria for a “variant of concern,” the highest alert level used by global health agencies. The virus continues to circulate and evolve, with several Omicron-descended lineages under monitoring, but none has shown the kind of dramatic increase in severity or immune evasion that triggered earlier waves. Seasonal patterns have emerged in many countries, with cases tending to rise in winter months. SARS-CoV-2 has, for practical purposes, joined the other four mild coronaviruses as a permanent part of the respiratory virus landscape, though it still causes more severe illness than a typical cold virus, especially in vulnerable populations.